Journal List > J Korean Soc Transplant > v.30(1) > 1034506

Nam, Yang, Lee, Joo, Han, Choi, and Choi: Single Center Experience of Biliary Reconstruction in Living Donor Liver Transplantation: Duct-to-Duct Anastomosis

Abstract

Background:

Duct-to-duct anastomosis is the most common biliary reconstruction method in living donor liver transplantation. However, biliary complications can frequently occur. The objective of this study was to examine biliary complications and related risk factors of patients with living donor liver transplantation during the last 12 years in our institution.

Methods:

Surgical outcomes of 252 consecutive patients with duct-to-duct anastomosis for biliary reconstruction in living donor liver transplantation between December 2000 and July 2012 were analyzed retrospectively.

Results:

Among the 252 patients, there were 65 cases (25.8%) of biliary complications. Before 2010, the incidence of biliary complications was 30.4% (56 of 184 cases). After 2011, the incidence was significantly (P<0.05) decreased to 13.2% (nine out of 68 cases). The complication rate of anastomosis of two separated bile ducts of graft to recipient two separated bile ducts using cystic duct and common bile duct of recipient was 50% (10 out of 20), which was relatively higher compared to that of single to single duct anastomosis (47 out of 191, 24.6%) or multiple duct to single duct anastomosis (eight out of 41, 19.5%).

Conclusions:

Duct to duct anastomosis between two separated bile ducts of a graft to two separated bile ducts of a recipient, the most common biliary reconstruction method, was associated with higher rate of biliary complications. Complications related to biliary reconstruction of living donor liver transplantation was gradually decreased. Standardization of bile duct anastomosis might lead to sequential reduction of biliary complications in living donor liver transplantations.

REFERENCES

1). Murray KF., Carithers RL Jr: AASLD. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology. 2005. 41:1407–32.
crossref
2). Vitale A., Morales RR., Zanus G., Farinati F., Burra P., Angeli P, et al. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. Lancet Oncol. 2011. 12:654–62.
crossref
3). de Villa VH., Lo CM., Chen CL. Ethics and rationale of living-donor liver transplantation in Asia. Transplantation. 2003. 75(3 Suppl):S2–5.
crossref
4). Kaido T., Uemoto S. Does living donation have advantages over deceased donation in liver transplantation? J Gastroenterol Hepatol. 2010. 25:1598–603.
crossref
5). Wan P., Yu X., Xia Q. Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis. Liver Transpl. 2014. 20:425–36.
crossref
6). Wachs ME., Bak TE., Karrer FM., Everson GT., Shrestha R., Trouillot TE, et al. Adult living donor liver transplantation using a right hepatic lobe. Transplantation. 1998. 66:1313–6.
crossref
7). Akamatsu N., Sugawara Y., Hashimoto D. Biliary reconstruction, its complications and management of biliary complications after adult liver transplantation: a systematic review of the incidence, risk factors and outcome. Transpl Int. 2011. 24:379–92.
crossref
8). Duailibi DF., Ribeiro MA Jr. Biliary complications following deceased and living donor liver transplantation: a review. Transplant Proc. 2010. 42:517–20.
crossref
9). Zimmerman MA., Baker T., Goodrich NP., Freise C., Hong JC., Kumer S, et al. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium. Liver Transpl. 2013. 19:259–67.
crossref
10). Wilson BJ., Marsh JW., Makowka L., Stieber AC., Koneru B., Todo S, et al. Biliary tract complications in orthotopic adult liver transplantation. Am J Surg. 1989. 158:68–70.
crossref
11). Soejima Y., Taketomi A., Yoshizumi T., Uchiyama H., Harada N., Ijichi H, et al. Biliary strictures in living donor liver transplantation: incidence, management, and technical evolution. Liver Transpl. 2006. 12:979–86.
crossref
12). Rouch DA., Emond JC., Thistlethwaite JR Jr., Mayes JT., Broelsch CE. Choledochocholedochostomy without a T tube or internal stent in transplantation of the liver. Surg Gynecol Obstet. 1990. 170:239–44.
13). Ju MK., Choi GH., Joo DJ., Hur KH., Choi J., Kim MS, et al. Use of the hilar plate looping technique for bile duct dissection in living donor liver transplantation significantly reduces recipient biliary complications. Transplant Proc. 2010. 42:4161–3.
crossref
14). Simoes P., Kesar V., Ahmad J. Spectrum of biliary complications following live donor liver transplantation. World J Hepatol. 2015. 7:1856–65.
crossref
15). Lee SG. Current status of liver transplantation in Korea. Korean J Gastroenterol. 2005. 46:75–83. (이승규, 국내 간이식 의 현황과 전망. 대한소화기학회지 2005;46: 75-83.).
16). Korean Network for Organ Sharing (KONOS). Statistics of organ transplantation [Internet]. Seoul: KONOS;c2014. [cited 2016 Mar 2]. Available from:. http://www.konos.go.kr.
17). Yang Y., Yan LN., Zhao JC., Ma YK., Huang B., Li B, et al. Microsurgical reconstruction of hepatic artery in A-A LDLT: 124 consecutive cases without HAT. World J Gastroenterol. 2010. 16:2682–8.
crossref
18). Seehofer D., Eurich D., Veltzke-Schlieker W., Neuhaus P. Biliary complications after liver transplantation: old problems and new challenges. Am J Transplant. 2013. 13:253–65.
crossref
19). Sugawara Y., Makuuchi M. Living donor liver transplantation: present status and recent advances. Br Med Bull. 2005. 75-76:15–28.
crossref
20). Yazumi S., Chiba T. Biliary complications after a right-lobe living donor liver transplantation. J Gastroenterol. 2005. 40:861–5.
crossref
21). Hwang S., Lee SG., Sung KB., Park KM., Kim KH., Ahn CS, et al. Long-term incidence, risk factors, and management of biliary complications after adult living donor liver transplantation. Liver Transpl. 2006. 12:831–8.
crossref
22). Ayuso JR., Ayuso C., Bombuy E., De Juan C., Llovet JM., De Caralt TM, et al. Preoperative evaluation of biliary anatomy in adult live liver donors with volumetric mangafodipir trisodium enhanced magnetic resonance cholangiography. Liver Transpl. 2004. 10:1391–7.
crossref
23). Ju MK., Kim MS., Choi GH., Chang HK., Ahn HJ., Kim YS, et al. The efficacy of pretransplant radiologic evaluation for graft volume and anatomy in living donor liver transplantation. J Korean Soc Transplant. 2007. 21:128–34. (주만기, 김명수, 최기홍, 장혜경, 안형준, 김유선, 등. 생체 간이식 공여자의 수술 전 이식간 용적과 해부학적 구조에 대한 영상학적 검사의 유용성. 대한이식학회지 2007;21: 128-34.).
24). Park S., Choi GS., Jung J., Cho G., Shin E., Lim C, et al. Clinical efficacy of pretransplant magnetic resonance cholangiography of donor for living donor liver transplantation. J Korean Soc Transplant. 2010. 24:311–5. (박승완, 김형철, 조규 석, 송옥평, 신응진, 임철완, 등. 생체간이식 수술에서 이식 전 제공자 자기공명담관조영술의 임상적 유용성. 대한이식학회지 2010;24: 311-5.).
crossref
25). Taketomi A., Morita K., Toshima T., Takeishi K., Kayashima H., Ninomiya M, et al. Living donor hepatectomies with procedures to prevent biliary complications. J Am Coll Surg. 2010. 211:456–64.
crossref
26). Takatsuki M., Eguchi S., Yamanouchi K., Hidaka M., Soyama A., Kanematsu T. Technical refinements of bile duct division in living donor liver surgery. J Hepatobiliary Pancreat Sci. 2011. 18:170–5.
crossref
27). Testa G., Malago M., Porubsky M., Marinov M., Sankary H., Oberholzer J, et al. Hilar early division of the hepatic duct in living donor right hepatectomy: the probe-and-clamp technique. Liver Transpl. 2006. 12:1337–41.
crossref
28). Lee KW., Joh JW., Kim SJ., Choi SH., Heo JS., Lee HH, et al. High hilar dissection: new technique to reduce biliary complication in living donor liver transplantation. Liver Transpl. 2004. 10:1158–62.
crossref
29). Li C., Mi K., Wen T., Yan L., Li B., Yang J, et al. A learning curve for living donor liver transplantation. Dig Liver Dis. 2012. 44:597–602.
crossref

Fig. 1.
Annual Incidence of living donor liver transplantation.
jkstn-30-6f1.tif
Fig. 2.
Annual biliary complication after living donor liver transplantation.
jkstn-30-6f2.tif
Table 1.
Clinical feature of the patients with duct-to-duct anastomosis
Variable Value
Sex (male/female) 191 (75.8)/61 (24.2)
Age (yr) 51.17±8.886
Original disease
  Cirrhosis, HBV 88 (34.9)
  Cirrhosis, HCV 6 (2.4)
  Cirrhosis, HBV+HCV 1 (0.4)
  Cirrhosis, alcoholic 16 (6.3)
  Cirrhosis, cryptogenic 2 (0.8)
  Cirrhosis, autoimmune 3 (1.2)
  Primary biliary cirrhosis 4 (1.6)
  Metabolic liver disease 3 (1.2)
  Acute liver failure 7 (2.8)
  Malignant, HCC 120 (47.6)
  Malignant, others 1 (0.4)
  Others 1 (0.4)
MELD score 14.98±8.03
Graft weight (g) 766.79±135.2
GRWR (%) 1.27±0.31
OP time (hr) 11.97±2.14
Intraoperative transfusion (unit)
  Red blood cells 7.71±9.21
  Fresh frozen plasma 6.98±7.22
  Platelet concentrate 3.13±6.31
Duration of hospital stay 32.97±27.58

Data are presented as number (%) or mean±SD.

Abbreviations: HBV, hepatitis B virus; HCV, hepatitis C virus; HCC, hepatocellular carcinoma; MELD, Model for End-Stage Liver Disease; GRWR, graft versus recipient weight ratio; OP, operation.

Table 2.
Comparison of biliary complication by operation period
  Until 2010 (n=184) Since 2011 (n=68) P-value
Biliary complication 56 (30.4) 9 (13.2) 0.006
Early developed 46 (25.0) 7 (10.3) 0.014
  biliary complication (within 3 mo)

Data are presented as number (%).

Table 3.
Donor factors associated with biliary complications
Factor Biliary complication P-value
Age (yr)
  <40 (n=193) 52 (26.9) 0.338
  ≥40 (n=58) 12 (20.7)  
Body mass index
  <24 (n=150) 40 (26.7) 0.299
  ≥24 (n=56) 11 (19.6)  
Graft weight (g)
  <700 (n=67) 20 (29.9) 0.226
  ≥700 (n=136) 30 (22.1)  
CIT (min)
  <120 (n=62) 15 (24.2) 0.342
  ≥120 (n=15) 3 (20.0)  
OP time (hr)
  <10 (n=18) 2 (11.1) 0.249
  ≥10 (n=163) 43 (26.4)  

Data are presented as number (%).

Abbreviations: CIT, cold ischemic time; OP, operation.

Table 4.
Recipient factors associated with biliary complications
Factor Biliary complication P-value
Age (yr)
  <50 (n=90) 26 (28.9) 0.403
  ≥50 (n=162) 39 (24.1)  
Body mass index
  <24 (n=149) 43 (28.9) 0.195
  ≥24 (n=102) 22 (21.6)  
Child-Pugh score
  A (n=123) 30 (24.4) 0.763
  B or C (n=115) 30 (26.1)  
MELD core
  <25 (n=207) 52 (25.1) 0.876
  ≥25 (n=38) 10 (26.3)  
GRWR (%)
  <1.0 4 (14.8) 0.189
  ≥1.0 47 (26.6)  

Data are presented as number (%).

Abbreviations: MELD, Model for End-Stage Liver Disease; GRWR, graft versus recipient weight ratio.

Table 5.
Biliary complication according to the type of anastomosis
Anastomosis type Total Biliary complication Stricture Leakage
Single jkstn-30-6t1.tif 191 47 (24.6) 38 (19.8) 9 (4.8)
Separated two jkstn-30-6t2.tif 20 10 (50.0) 8 (40) 2 (10)
Multiple to one jkstn-30-6t3.tif 41 8 (19.5) 6 (14.6) 2 (4.9)

Data are presented as number (%).

TOOLS
Similar articles